Tessera Therapeutics
This role involves collaborating with experimental scientists and platform teams to design, analyze, and interpret multi-omics data focused on understanding gene writing systems. The position requires developing computational methods and tools for processing molecular data, presenting scientific findings to drive decision-making, and contributing to genotoxicity risk assessments. The ideal candidate will work in a hybrid capacity in Somerville, MA, supporting drug candidate programs through scalable data infrastructure and knowledge mining.
Headquarters
Somerville, Massachusetts, United States
Company Size
201-500 employees
Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing™, a new biotechnology designed to offer scientists and doctors the…
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tessera Therapeutics.
13% above the average for this role